Jingjing Ben

Jingjing Ben

Auto-generated profile, based on publicly available information

Jingjing Ben

Department of Pathophysiology, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, China

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
JBJingjing Ben
Jingjing Ben
BJBin Jiang
Bin Jiang
DWDongdong Wang
Dongdong Wang
QLQingling Liu
Qingling Liu
YZYongjing Zhang
Yongjing Zhang
QCQi Chen
Qi Chen
Macrophage-orchestrated, low-grade chronic inflammation plays a pivotal role in obesity and atherogenesis. However, the underlying regulatory mechanisms remain incompletely understood. Here, we identify major vault protein (MVP), the main component of unique cellular ribonucleoprotein particles, as a suppressor for NF-κB signaling in macrophages. Both global and myeloid-specific MVP gene knockout aggravates high-fat diet induced obesity, insulin resistance, hepatic steatosis and atherosclerosis in mice. The exacerbated metabolic disorders caused by MVP deficiency are accompanied with increased macrophage infiltration and heightened inflammatory responses in the microenvironments. In vitro studies reveal that MVP interacts with TRAF6 preventing its recruitment to IRAK1 and subsequent oligomerization and ubiquitination. Overexpression of MVP and its α-helical domain inhibits the activity of TRAF6 and suppresses macrophage inflammation. Our results demonstrate that macrophage MVP constitutes a key constraint of NF-κB signaling thereby suppressing metabolic diseases.

3 March 2022 in Molecular Metabolism
Verified
Journal Article
Open access
BJBin Jiang
Bin Jiang
DWDongdong Wang
Dongdong Wang
YHYunfu Hu
Yunfu Hu
WLWenxuan Li
Wenxuan Li
FLFengjiang Liu
Fengjiang Liu
QCQi Chen
Qi Chen
Chronic inflammatory response plays a prominent role in obesity-related nonalcoholic fatty liver disease (NAFLD). However, the intrahepatic triggering mechanism of inflammation remains obscure. This study aimed to elucidate the role of serum amyloid A1 (SAA1), an acute-phase response protein, in the obesity-induced hepatic inflammation and NAFLD. Male mice were fed a high fat diet (HFD) for 16 weeks, and insulin resistance, hepatic steatosis, and inflammation in mice were monitored. Murine SAA1/2 was genetically manipulated to investigate the role of SAA1 in NAFLD. We found that SAA1 was increased in the NAFLD liver in both humans and mice. Knockout of SAA1/2 or knockdown of hepatic SAA1/2 promoted energy expenditure and alleviated HFD-induced metabolic disorder, hepatic steatosis, and inflammation. Endogenous overexpression of SAA1 in hepatocytes by adeno-associated virus 8 (AAV8) transfection aggravated overnutrition-associated gain of body weight, insulin resistance, hepatic lipid accumulation, and liver injury, which were markedly alleviated by knockout of murine toll-like receptor 4 (TLR4). Mechanistically, SAA1 directly bound with TLR4/myeloid differentiation 2 (MD2) to induce TLR4 internalization, leading to the activation of nuclear factor (NF)-κB signaling and production of both SAA1 and other inflammatory cytokines, including interleukin (IL)-6 and C–C chemokine ligand (CCL2) in hepatocytes. Administration of HFD mice with an AAV8-shRNA-SAA1/2 showed a therapeutic effect on hepatic inflammation and NAFLD progression. These results demonstrate that SAA1 triggers hepatic steatosis and intrahepatic inflammatory response by forming a SAA1/TLR4/NF-κB/SAA1 feedforward regulatory circuit, which, in turn, leads to NAFLD progression. SAA1 may act as a potential target for the disease intervention.

19 July 2011 in Basic Research in Cardiology
Verified
Journal Article
Closed access
PDF file
YHYulong Hu
Yulong Hu
HZHanwen Zhang
Hanwen Zhang
YLYan Lu
Yan Lu
HBHui Bai
Hui Bai
YXYiming Xu
Yiming Xu
QCQi Chen
Qi Chen

10 November 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
JJJinchao Jia
Jinchao Jia
MWMengyan Wang
Mengyan Wang
JMJianfen Meng
Jianfen Meng
YMYuning Ma
Yuning Ma
YWYang Wang
Yang Wang
QHQiongyi Hu
Qiongyi Hu
Hyperferritinemic syndrome, an overwhelming inflammatory condition, is characterized by high ferritin levels, systemic inflammation and multi-organ dysfunction, but the pathogenic role of ferritin remains largely unknown. Here we show in an animal model that ferritin administration leads to systemic and hepatic inflammation characterized by excessive neutrophil leukocyte infiltration and neutrophil extracellular trap (NET) formation in the liver tissue. Ferritin-induced NET formation depends on the expression of peptidylarginine deiminase 4 and neutrophil elastase and on reactive oxygen species production. Mechanistically, ferritin exposure increases both overall and cell surface expression of Msr1 on neutrophil leukocytes, and also acts as ligand to Msr1 to trigger the NET formation pathway. Depletion of neutrophil leukocytes or ablation of Msr1 protect mice from tissue damage and the hyperinflammatory response, which further confirms the role of Msr1 as ferritin receptor. The relevance of the animal model is underscored by the observation that enhanced NET formation, increased Msr1 expression and signalling on neutrophil leukocytes are also characteristic to adult-onset Still’s disease (AOSD), a typical hyperferritinemic syndrome. Collectively, our findings demonstrate an essential role of ferritin in NET-mediated cytokine storm, and suggest that targeting NETs or Msr1 may benefit AOSD patients.

1 January 2021 in Theranostics
Verified
Journal Article
Open access
LYLichan Yuan
Lichan Yuan
NZNa Zhao
Na Zhao
JWJunyi Wang
Junyi Wang
YLYuying Liu
Yuying Liu
LMLi Meng
Li Meng
JMJunqing Ma
Junqing Ma
Rationale: Bone homeostasis is maintained by a balanced interplay of osteoblasts and osteoclasts. Osteoclasts are derived from monocyte/macrophage lineage. Major vault protein (MVP) is known to promote apoptosis and prevent metabolic diseases in macrophage. However, whether MVP is involved in osteoclastogenesis is unknown. Here, we identified an important function of MVP as a negative regulator of osteoclastogenesis and its therapeutic potential in preventing bone loss.

17 April 2025 in Drug Resistance Updates
Verified
Journal Article
Closed access
JXJiawen Xu
Jiawen Xu
BWBo Wang
Bo Wang
QLQiaoyu Liu
Qiaoyu Liu
SGSheng Guo
Sheng Guo
CCChen Chen
Chen Chen
SWShouyu Wang
Shouyu Wang